Literature DB >> 29366906

Intratumor heterogeneity in epigenetic patterns.

Yassen Assenov1, David Brocks1, Clarissa Gerhäuser2.   

Abstract

Analogous to life on earth, tumor cells evolve through space and time and adapt to different micro-environmental conditions. As a result, tumors are composed of millions of genetically diversified cells at the time of diagnosis. Profiling these variants contributes to understanding tumors' clonal origins and might help to better understand response to therapy. However, even genetically homogenous cell populations show remarkable diversity in their response to different environmental stimuli, suggesting that genetic heterogeneity does not explain the full spectrum of tumor plasticity. Understanding epigenetic diversity across cancer cells provides important additional information about the functional state of subclones and therefore allows better understanding of tumor evolution and resistance to current therapies.
Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  (Sub-)clonal evolution; Cancer stem cells; Chromatin; DNA methylation; Epigenetic intratumor heterogeneity; Epigenetic therapy; Histone posttranscriptional modifications; Single-cell analysis

Mesh:

Year:  2018        PMID: 29366906     DOI: 10.1016/j.semcancer.2018.01.010

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  19 in total

1.  Comprehensive mapping of the methylation landscape of 16 CpG-dense regions in oral and pharyngeal squamous cell carcinoma.

Authors:  Scott M Langevin; Damaris Kuhnell; Liang Niu; Jacek Biesiada; Yuet-Kin Leung; Ranjan Deka; Aimin Chen; Mario Medvedovic; Karl T Kelsey; Susan Kasper; Xiang Zhang
Journal:  Epigenomics       Date:  2019-06-19       Impact factor: 4.778

2.  Identification and Quantification of Heterogeneously-methylated DNA Fragments Using Epiallele-sensitive Droplet Digital Polymerase Chain Reaction (EAST-ddPCR).

Authors:  Mario Menschikowski; Carsten Jandeck; Markus Friedemann; Susan Richter; Dana Thiem; Björn Sönke Lange; Meinolf Suttorp
Journal:  Cancer Genomics Proteomics       Date:  2018 Jul-Aug       Impact factor: 4.069

3.  Overexpression of Histone H3 Lysine 27 Trimethylation Is Associated with Aggressiveness and Dedifferentiation of Thyroid Cancer.

Authors:  Chia-Chi Tsai; Ming-Nan Chien; Yuan-Ching Chang; Jie-Jen Lee; Shuen-Han Dai; Shih-Ping Cheng
Journal:  Endocr Pathol       Date:  2019-12       Impact factor: 3.943

4.  Exploring effects of DNA methylation and gene expression on pan-cancer drug response by mathematical models.

Authors:  Wenhua Lv; Xingda Zhang; Huili Dong; Qiong Wu; Baoqing Sun; Yan Zhang
Journal:  Exp Biol Med (Maywood)       Date:  2021-04-28

Review 5.  Tumor microenvironment heterogeneity an important mediator of prostate cancer progression and therapeutic resistance.

Authors:  Rongbin Ge; Zongwei Wang; Liang Cheng
Journal:  NPJ Precis Oncol       Date:  2022-05-04

6.  Cell type-specific genome scans of DNA methylation divergence indicate an important role for transposable elements.

Authors:  Önder Kartal; Marc W Schmid; Ueli Grossniklaus
Journal:  Genome Biol       Date:  2020-07-13       Impact factor: 13.583

7.  SIRT1 inhibits chemoresistance and cancer stemness of gastric cancer by initiating an AMPK/FOXO3 positive feedback loop.

Authors:  Yifei An; Bo Wang; Xin Wang; Guoying Dong; Jihui Jia; Qing Yang
Journal:  Cell Death Dis       Date:  2020-02-12       Impact factor: 8.469

8.  CancerTracer: a curated database for intrapatient tumor heterogeneity.

Authors:  Chen Wang; Jian Yang; Hong Luo; Kun Wang; Yu Wang; Zhi-Xiong Xiao; Xiang Tao; Hao Jiang; Haoyang Cai
Journal:  Nucleic Acids Res       Date:  2020-01-08       Impact factor: 16.971

Review 9.  The Intricate Interplay between Epigenetic Events, Alternative Splicing and Noncoding RNA Deregulation in Colorectal Cancer.

Authors:  Raheleh Amirkhah; Hojjat Naderi-Meshkin; Jaynish S Shah; Philip D Dunne; Ulf Schmitz
Journal:  Cells       Date:  2019-08-19       Impact factor: 6.600

Review 10.  Clinical implications of intratumor heterogeneity: challenges and opportunities.

Authors:  Santiago Ramón Y Cajal; Marta Sesé; Claudia Capdevila; Trond Aasen; Leticia De Mattos-Arruda; Salvador J Diaz-Cano; Javier Hernández-Losa; Josep Castellví
Journal:  J Mol Med (Berl)       Date:  2020-01-22       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.